ArticleTzu chi medical journal

Transarterial chemoembolization with or without sorafenib for hepatocellular carcinoma: A real-world propensity score-matched study.

Tzu-Rong Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.